Valeritas (NSDQ:VLRX) said today that the American Diabetes Association has endorsed the use of “disposable patch-like devices” for insulin delivery, which includes its V-Go wearable insulin delivery device.

The Bridgewater, N.J.-based company said that the endorsement was made as part of the the ADA’s annual Standards of Medical Care for 2019, published in the journal Diabetes Care in the new Diabetes Technology chapter.

Read the whole story on our sister site, Drug Delivery Business News